Full text is available at the source.
Abstract
The algorithm-optimized H5 mRNA vaccine induced high levels of neutralizing antibodies against multiple clade 2.3.4.4b H5 viruses.
- Cross-species transmission and evolution of H5 avian influenza viruses pose a significant pandemic threat.
- Existing seasonal and licensed H5 vaccines offer limited protection against H5 viruses.
- Bioinformatics analysis of human-infected H5 hemagglutinin sequences guided the design of a novel vaccine.
- The predicted structure of the new vaccine closely resembles the natural H5 HA trimer.
- Animal studies showed the vaccine candidate elicited cross-neutralizing antibodies against various H5 virus clades.
- Robust cellular immune responses were also observed in response to the vaccine.
Simplified